Central nervous system mediated inhibition of insulin secretion due to 2-deoxyglucose.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D001120:Arginine / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects / Q000502:physiology*; D002552:Cerebral Ventricles; D005260:Female; D005947:Glucose / Q000378:metabolism / Q000494:pharmacology*; D006943:Hyperglycemia / Q000139:chemically induced; D007328:Insulin / Q000097:blood* / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000294:innervation / Q000378:metabolism / Q000502:physiology; D010525:Peripheral Nerves / Q000187:drug effects; D051381:Rats; D013329:Structure-Activity Relationship; D013564:Sympathetic Nervous System / Q000187:drug effects; D013997:Time Factors
D007328:Insulin; D001120:Arginine; D005947:Glucose